These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7313358

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of oral disopyramide phosphate on induction of paroxysmal supraventricular tachycardia.
    Swiryn S, Bauernfeind RA, Wyndham CR, Dhingra RC, Palileo E, Strasberg B, Rosen KM.
    Circulation; 1981 Jul; 64(1):169-75. PubMed ID: 7237716
    [Abstract] [Full Text] [Related]

  • 23. Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
    Camm J, Ward D, Washington HG, Spurrell RA.
    Pacing Clin Electrophysiol; 1979 Jul; 2(4):395-402. PubMed ID: 95308
    [Abstract] [Full Text] [Related]

  • 24. [Evaluation of antiarrhythmic agents by means of artificial provocation of supraventricular tachycardia (author's transl)].
    Atarashi H.
    Nihon Ika Daigaku Zasshi; 1981 Feb; 48(1):12-25. PubMed ID: 7309829
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Disopyramide in pregnancy: a case report.
    Shaxted EJ, Milton PJ.
    Curr Med Res Opin; 1979 Feb; 6(1):70-2. PubMed ID: 456013
    [Abstract] [Full Text] [Related]

  • 27. [Disopyramide in the prevention of arrhythmia following myocardial infarction and resistant arrhythmia].
    Dallocchio M, Daubeze J, Clementy J, Poisot D, Bricaud H, Broustet P.
    Therapie; 1974 Feb; 29(1):119-29. PubMed ID: 4848509
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Clinical efficacy of disopyramide in the treatment of cardiac arrhythmias (author's transl)].
    Li JC.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Dec; 8(4):260-3. PubMed ID: 7307962
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A double-blind trial of disopyramide, procaineamide and digoxin in paroxysmal suptraventricular tachycardia.
    Millar-Craig MW, Raftery EB.
    Clin Cardiol; 1979 Jun; 2(3):179-84. PubMed ID: 389512
    [Abstract] [Full Text] [Related]

  • 36. [Echocardiographic indices of cardiac function and systemic hemodynamics in patients with cardiac fibrillation paroxysms and their dynamics as affected by disopyramide phosphate].
    Komarov FI, Ol'binskaia LI, Kuz'mina MM.
    Kardiologiia; 1985 Jul; 25(7):71-4. PubMed ID: 3932741
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM, Olesin AI.
    Ter Arkh; 1996 Jul; 68(5):57-60. PubMed ID: 9082603
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.